Physician profile
John Hoffman
NPI 1407166499
$1,053.78
in general payments reported to CMS, 2019-2025
13 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $16.25 · 2021: $24.57 · 2022: $88.33 · 2023: $125 · 2024: $325 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $639.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $201.76 | 2019-2025 | Rocklatan, Simbrinza |
| Abbvie INC. | $152.67 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $131.28 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Harrow Eye, LLC | $119.35 | 2024-2025 | Vevye |
| Shire North American Group INC | $109.72 | 2019 | |
| Sun Pharmaceutical Industries INC. | $78.17 | 2023-2024 | Cequa |
| Coopervision INC. | $65.20 | 2019 | |
| Dompe US, INC. | $56.88 | 2024 | Oxervate |
| Oyster Point Pharma, INC. | $53.13 | 2024 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $31.31 | 2023 | |
| Astellas Pharma US INC | $18.82 | 2024 | Izervay |
| Allergan, INC. | $17.79 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $17.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.